focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMED.L Regulatory News (MED)

  • There is currently no data for MED

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Adjustment to Options

21 Jan 2005 09:14

MicroEmissive Displays Group PLC21 January 2005 21 January 2005 MicroEmissive Displays Group plc MicroEmissive Displays Group plc (the "Company") announces that following thereorganisation of the Company's share capital effected by a special resolutionof the Company passed on 16 November 2004, the number of shares subject tooutstanding options granted by the Company: (i) under the MEDG EMI Schemeadopted by the Company on 2 October 2004 (the "MEDG EMI Scheme"); (ii) under theunapproved scheme also adopted by the Company on 2 October 2004 (the "MEDGUnapproved Scheme"); (iii) pursuant to certain unapproved option agreements withthe Company (the "Unapproved Agreements"); and (iv) pursuant to certain EMIoption agreements with the Company (the "EMI Agreements"), and the exerciseprices per share of those options were adjusted on 5 January 2005 in accordancewith the terms of those options. As a result of the adjustment, the optionsgranted under the MEDG EMI Scheme and the MEDG Unapproved Scheme and pursuant tothe Unapproved Agreements and the EMI Agreements over ordinary shares of 65peach in the capital of the Company ("Ordinary Shares") are as follows: 1. MEDG EMI Scheme Deemed Exercise price Period exercisable Total optionsDate of Grant per share outstanding8 August 2001 £9.80 30 months following the deemed date of 41 grant until the tenth anniversary of deemed date of grant. From 7 May 2003 £9.80 From the third anniversary of the deemed 973to 2 June 2003 date of grant until the tenth anniversary of deemed date of grant. From 25 November 2003 to £0.98 From the third anniversary of the deemed 475,16930 November 2003 date of grant until the tenth anniversary of deemed date of grant. From 1 October 2004 to £0.98 The options vest over a period of 36 months 178,275 from the deemed date of grant and remain4 October 2004 exercisable until the tenth anniversary of the deemed date of grant. From 1 October 2004 to £0.98 From the third anniversary of the deemed 23,9354 October 2004 date of grant until the tenth anniversary of deemed date of grant, subject to a performance condition being satisfied. 2. MEDG Unapproved Scheme Deemed Exercise price Period exercisable Total options Date of Grant per share outstanding24 April 2003 £0.98 From the third anniversary of the deemed 170,707 date of grant until the tenth anniversary of the deemed date of grant 1 October 2004 £0.98 The options vest over a period of 36 months 74,685 from the deemed date of grant and remain exercisable until the tenth anniversary of the deemed date of grant. 1 October 2004 £0.98 From the third anniversary of the deemed 58,225 date of grant until the tenth anniversary of the deemed date of grant, subject to a performance condition being satisfied. 3. Unapproved Agreements Deemed Exercise Period exercisable Total optionsName Date of price outstanding Grant per share Peter Denyer 23 May 2003 £9.80 The option vests in tranches until 1 1,126 September 2004 and remains exercisable until the tenth anniversary of the deemed date of grant. Paul Strzelecki 7 June 2003 £9.80 The option vests in tranches until 1 382 September 2004 and remains exercisable until the tenth anniversary of the deemed date of grant. Jed Hurwitz 23 May 2003 £9.80 The option vests in tranches until 1 81 September 2004 and remains exercisable until the tenth anniversary of the deemed date of grant. Peter Denyer 1 December 2003 £0.98 From the third anniversary of the deemed 119,041 date of grant until the tenth anniversary of the deemed date of grant. Paul Strzelecki 5 December 2003 £0.98 From the third anniversary of the deemed 13,527 date of grant until the tenth anniversary of the deemed date of grant. Jed Hurwitz 19 January 2004 £0.98 From the third anniversary of the deemed 11,552 date of grant until the tenth anniversary of the deemed date of grant. William Freer 16 December 2003 £0.98 From the third anniversary of the deemed 13,527 date of grant until the tenth anniversary of deemed date of grant. Kenneth Sanders 4 February 2004 £0.98 From the third anniversary of the deemed 13,527 date of grant until the tenth anniversary of the deemed date of grant. Peter Denyer 1 October 2004 £0.98 The options vest over a period of 36 24,033 months from the deemed date of grant and remain exercisable until the tenth anniversary of the deemed date of grant. Paul Strzelecki 1 October 2004 £0.98 The options vest over a period of 36 15,079 months from the deemed date of grant and remain exercisable until the tenth anniversary of the deemed date of grant. Kenneth Sanders 4 October 2004 £0.98 The options vest over a period of 36 8,734 months from the deemed date of grant and remain exercisable until the tenth anniversary of the deemed date of grant. Peter Denyer 1 October 2004 £0.98 From the third anniversary of the 15,933 deemed date of grant until the tenth anniversary of the deemed date of grant, subject to a performance condition being satisfied. Paul Strzelecki 1 October 2004 £0.98 From the third anniversary of the 3,203 deemed date of grant until the tenth anniversary of the deemed date of grant, subject to a performance condition being satisfied. Kenneth Sanders 4 October 2004 £0.98 From the third anniversary of the 2,459 deemed date of grant until the tenth anniversary of the deemed date of grant, subject to a performance condition being satisfied. 4. EMI Agreements Name Deemed Exercise Period exercisable Total options Date of price outstanding Grant per share Jeff Wright 5 May 2003 £9.80 The option vests in tranches from 1 1,915 April 2003 until 1 September 2004 and is thereafter exercisable in full until the tenth anniversary of the grant date.Ian Underwood 12 May 2003 £9.80 The option vests in tranches from 1 1,915 April 2003 until 1 September 2004 and is thereafter exercisable in full until the tenth anniversary of the grant date.William Campbell 7 May 2003 £9.80 The option vests in tranches from 7 May 1,915 2003 until 7 May 2006 and is thereafter exercisable in full until the tenth anniversary of the grant date. In summary, as at the date of this announcement, there are outstanding optionsheld under the MEDG EMI Scheme and the MEDG Unapproved Scheme and pursuant tothe Unapproved Agreements and the EMI Agreements over an aggregate of 1,229,959Ordinary Shares and there are 17,131,575 Ordinary Shares in issue. As a result of the adjustment, the directors are interested in options over thefollowing numbers of Ordinary Shares at the following exercise prices: Number of options Exercise price Alan Bennie 104,769 £0.98 William Campbell 1,915 £9.80 231,275 £0.98 Peter Denyer 1,126 £9.80 159,007 £0.98 Kenneth Sanders 24,720 £0.98 Paul Strzelecki 382 £9.80 31,809 £0.98 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
14th Jan 201911:34 amRNSChange of Name
7th Jan 20197:00 amRNSTrading Update
14th Dec 20181:05 pmRNSHolding(s) in Company
13th Dec 20188:30 amRNSDirector/PDMR Shareholding
12th Dec 20181:24 pmRNSResults of General Meeting and Total Voting Rights
12th Dec 20187:00 amRNSResults of Open Offer
27th Nov 20183:35 pmRNSAI database exceeds 1 million images
26th Nov 20187:00 amRNSPlacing to raise £5.0m
23rd Nov 20183:56 pmRNSMedaPhor commences clinical trial for AnatomyGuide
13th Nov 20187:00 amRNSQuality control on ultrasound for HAPIN trial
9th Nov 20187:00 amRNSINTERGROWTH-21st Project the University of Oxford
10th Oct 20182:59 pmRNSHolding(s) in Company
9th Oct 20188:01 amRNSDirector/PDMR Shareholding
8th Oct 20187:00 amRNSPayment of deferred consideration
25th Jul 20187:00 amRNSHalf-year Report
23rd Jul 20187:00 amRNSMedaphor expands ScanNav AI pilot
7th Jun 20187:00 amRNSScanTrainer at Central Middlesex Hospital
30th May 20187:00 amRNSGrant of Options
29th May 20187:00 amRNSBodyWorks Eve installed at NYU School of Medicine
17th May 201810:54 amRNSResult of AGM
17th May 20187:00 amRNSAGM Statement
14th May 20187:00 amRNSScanNav AI software featured on ITV
24th Apr 20187:00 amRNSNotice of AGM
21st Mar 20187:00 amRNSFinal Results
5th Mar 20187:00 amRNSNotice of Results
21st Feb 20187:00 amRNSOpening of Hong Kong office
19th Feb 20187:00 amRNSLaunch of new Point-of-Care Ultrasound simulator
12th Feb 20187:00 amRNSPilot of ultrasound AI software for pregnancy scan
7th Feb 20187:00 amRNSInvestor presentation
5th Feb 20187:00 amRNSInnovate UK grant award confirmed
3rd Jan 20187:00 amRNSTrading and IUL integration update
23rd Nov 20177:00 amRNSInnovate UK Grant Award
30th Oct 20173:19 pmRNSDirector Appointment
18th Oct 201712:46 pmRNSHolding(s) in Company
17th Oct 201711:05 amRNSSecond Price Monitoring Extn
17th Oct 201711:00 amRNSPrice Monitoring Extension
11th Oct 20178:17 amRNSHolding(s) in Company
10th Oct 20171:55 pmRNSHolding(s) in Company
9th Oct 20173:23 pmRNSHolding(s) in Company
9th Oct 20172:51 pmRNSHolding(s) in Company
6th Oct 20178:00 amRNSCompletion of Acquisition
5th Oct 201711:18 amRNSResult of General Meeting
21st Sep 20171:31 pmRNSHolding(s) in Company
21st Sep 20177:00 amRNSContract awarded at Mohawk College in Canada
19th Sep 20173:40 pmRNSAcquisition & Placing
17th Aug 20177:00 amRNSInstallation of 500th simulation system
10th Aug 20178:37 amRNSPayment of deferred consideration
31st Jul 20177:00 amRNSHalf-year Report
24th Jul 20177:00 amRNSMedaPhor wins first ScanTrainer customer in India
23rd May 201711:44 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.